Please ensure Javascript is enabled for purposes of website accessibility

Why ViewRay Stock Got Crushed Today

By Eric Volkman - Jan 22, 2021 at 5:51PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A big investor sells out of the company.

What happened

ViewRay (VRAY 2.13%) slid out of view for many investors on Friday. The maker of next-generation radiation therapy devices saw its stock dive by over 15% on the day, after a peer sold a big chunk of the company's shares.

So what

Elekta (EKTAY 3.36%), a Swedish company active in the same segment, announced Friday that it sold its 7%-plus stake in ViewRay, a divestment that amounted to just over 11.5 million shares. That's a complete sell-out, as Elekta added that it no longer holds any shares.

Hand in a nitrile glove holding a beaker full of $100 bills

Image source: Getty Images.

Elekta originally committed to buying its stake in ViewRay in December 2019, as part of the latter company's initial public offering (IPO). In buying the stock, Elekta also signed a memorandum of understanding with ViewRay to "advance the knowledge and application of [magnetic resonance]-guided radiation therapy."

Elekta did not provide any reasons for its sell-off. Unlike many investors who are sticking with ViewRay, Elekta is walking away richer after its divestment -- its stake was sold at $4.65 per share, well up from the $3.13 it paid in the 2019 deal.

Elekta also did not address the fate of its collaboration agreement with ViewRay, although we can surmise it's no longer in force.

Now what

It's always tough news when a company loses either a key investor or an important collaborator; ViewRay seems to have lost both. So the healthcare company, already struggling with its financials, will have an additional burden to shoulder.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

ViewRay, Inc. Stock Quote
ViewRay, Inc.
VRAY
$2.87 (2.13%) $0.06
Elekta AB (publ) Stock Quote
Elekta AB (publ)
EKTAY
$7.08 (3.36%) $0.23

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.